A Trial of Lu AF28996 in Participants With Parkinson's Disease (PD) Trial Phase 1 Not yet recruiting April 6, 2026
A Study to Assess Change in Disease Symptoms in Adult Participants With Advanced Parkinson Disease Using Subcutaneous Foslevodopa/Foscarbidopa in Belgium Trial N/A Recruiting April 6, 2026
Telemedicine Intervention in Patients With Chronic Pain in PD Trial N/A Active, not recruiting April 6, 2026
A Trial Investigating Lu AF28996 in Adults With Parkinson's Disease Who Have Motor Fluctuations Trial Phase 2 Not yet recruiting April 6, 2026
A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations Trial Phase 2 Recruiting April 5, 2026
A Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of UCB0022 in Study Participants With Advanced Parkinson's Disease Trial Phase 2 Completed April 5, 2026
Low Voltage Electrical Stimulation for Depression in Parkinson's Patients Trial N/A Recruiting April 5, 2026
Amantadine and L-DOPA-induced Dyskinesia in Early Parkinson's Disease Trial Phase 2 Completed April 5, 2026
Behavioral and/or Mirabegron to Treat Urinary Symptoms in Parkinson Disease Trial Phase 4 Not yet recruiting April 5, 2026
Testing of an Interface for Synchronizing tACS-DBS With a Phase-locked-loop Trial N/A Recruiting April 2, 2026
Ultra-High Resolution PET in Aging, Neurodegeneration and Psychotic Disorders Trial N/A Recruiting April 2, 2026
CS1P1 PET Studies of Neuroinflammation in Parkinson Disease Trial N/A Enrolling by invitation April 1, 2026
An Extension Study to Evaluate the Long-Term Efficacy, Safety and Tolerability of Minzasolmin (UCB0599) in Study Participants With Parkinson's Disease Trial Phase 2 Terminated April 1, 2026
An Integrated and Personalized Lifestyle Approach for People With Parkinson's Disease Trial N/A Active, not recruiting March 31, 2026
Primary Parkinsonian Pain Diagnostic Questionnaire: Development and Validation of This Questionnaire Trial N/A Completed March 31, 2026